May 28, 2025 04:05PM
Mar 21, 2025 04:30AM
Oct 15, 2024 05:53AM
May 29, 2024 04:05PM
Nov 9, 2023 04:05PM
May 24, 2023 04:05PM
May 26, 2022 08:00AM Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences
May 26, 2022 08:00AM
May 20, 2021 04:05PM
May 20, 2021 04:05PM
Mar 8, 2021 09:32AM
Aug 11, 2020 09:51AM
Jul 16, 2020 05:52AM
Jul 15, 2020 07:47PM Adaptive Biotechnologies Announces Pricing of Public Offering of Common Stock
Jul 15, 2020 07:47PM
Jul 14, 2020 04:45PM
Jul 14, 2020 04:44PM
Jul 14, 2020 04:44PM
May 27, 2020 04:03PM
May 27, 2020 04:03PM
Apr 28, 2020 06:00AM Sweetwater Private Equity recognizes Adaptive Biotechnologies Corp. and its CEO Chad Robins for leadership during COVID-19 crisis
Jan 24, 2020 05:42AM
Jan 23, 2020 08:53PM
Jan 23, 2020 08:53PM
Jan 21, 2020 04:40PM
Jan 21, 2020 04:39PM
Jan 21, 2020 04:39PM
Aug 14, 2019 06:20AM Adeptus Biotechnologies Corp. (ADPT) PT Raised to $36 at Goldman Sachs
Jul 22, 2019 02:32AM
Jul 1, 2019 04:05PM
Jul 1, 2019 04:05PM
Jun 27, 2019 06:24AM
Jun 26, 2019 07:57PM
Jun 26, 2019 07:57PM
Nov 4, 2016 06:35AM Goldman Sachs Downgrades Adeptus Health (ADPT) to Neutral
Nov 1, 2016 04:31PM
Nov 1, 2016 04:15PM
Oct 11, 2016 04:51PM
Jun 3, 2016 07:00AM
Jun 1, 2016 09:25AM
Mar 10, 2016 11:54AM
Feb 1, 2016 03:05PM Form SC 13G/A Adeptus Health Inc. Filed by: GOLDMAN SACHS ASSET MANAGEMENT, L.P.
Dec 10, 2015 04:40PM
Jun 5, 2015 06:56AM
Jun 3, 2015 07:00AM
Feb 12, 2015 01:09PM
Nov 12, 2014 06:00AM

184,687 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All